Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ENTX compared with ACIU: revenue, margins and what each company keeps, and the suppliers and customers both name
ENTX
Entera Bio Ltd.
Change
Mkt cap
Revenue
Revenue
ACIU
AC Immune SA
Change
Mkt cap
Revenue
Revenue
vs
Compare
ENTX
Entera Bio Ltd.
vs
ACIU
AC Immune SA
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ENTX, solid
ACIU, dashed
Supply-chain overlap
Revenue flow
ENTX: latest quarter is a loss; flow not drawable. ACIU: latest quarter not drawable.
Method
›
ENTX
Entera Bio Ltd.
Change
3.21
▲
+2.88%
· post 3.21
Mkt cap
$161.4M
Revenue
$42,000
Q1 FY25
ACIU
AC Immune SA
Change
2.22
▼
−6.14%
· post 2.23
Closed
Oct 30 '26
Mkt cap
$222.9M
Revenue
—
vs
Compare
Closed
Oct 30 '26
ENTX
Entera Bio Ltd.
vs
ACIU
AC Immune SA
3.21
▲
+2.88%
post 3.21
Price
2.22
▼
−6.14%
post 2.23
$161.4M
Mkt cap
$222.9M
Q1 FY25
$42,000
Revenue
—
Change
Change
ENTX
3.21
▲
+2.88%
vs
ACIU
2.22
▼
−6.14%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ENTX
1
OPK
OPKO Health
supplier
Shared
0
No shared counterparties.
Only ACIU
4
LLY
Eli Lilly
customer
JNJ
Janssen Pharmaceuticals
customer
LNTH
Lantheus
customer
TAK
Takeda Pharmaceuticals USA
customer
Role chip = supplier or customer
Source: SEC EDGAR